VentriPoint Diagnostics Ltd.
VPTDF
Rank in Stocks
#29105
VentriPoint Diagnostics Ltd. is a medical technology company focused on... VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.
Share Price
$0.0479
Last synced: 2026-11-09
Market Cap
$8.88M
Change (1 day)
-2.74%
Change (1 year)
-33.19%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade VentriPoint Diagnostics Ltd. (VPTDF)
Category
Healthcare
Operating Margin for VentriPoint Diagnostics Ltd. (VPTDF)
Operating Margin as of November 2026 TTM: -1,624.48%
According to VentriPoint Diagnostics Ltd.'s latest financial reports, its current operating margin (TTM) is -1,624.48%. At the end of 2025 the company had an operating margin of -1,889.37%.
Operating Margin history for VentriPoint Diagnostics Ltd. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,624.48% | -14.02% |
| 2025 | -1,889.37% | -62.55% |
| 2024 | -5,045.41% | -49.67% |
| 2023 | -10,024.80% | 39.16% |
| 2022 | -7,203.96% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -5,245.01% | 29.45% |
| 2019 | -4,051.66% | -36.23% |
| 2018 | -6,353.31% | -27.13% |
| 2017 | -8,718.55% | 785.75% |
| 2016 | -984.31% | -72.64% |
| 2015 | -3,597.22% | 135.96% |
| 2014 | -1,524.49% | -67.25% |
| 2013 | -4,654.28% | 251.49% |
| 2012 | -1,324.15% | -50.53% |
| 2011 | -2,676.73% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.01% |
US
|
|
| 18.08% | -100.01% |
IE
|
|
| 21.25% | -100.01% |
US
|
|
| 21.05% | -100.01% |
US
|
|
| 28.09% | -100.02% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about VentriPoint Diagnostics Ltd.'s operating margin
What is VentriPoint Diagnostics Ltd.'s operating margin?
VentriPoint Diagnostics Ltd.'s operating margin is -1,624.48%, as of Nov 2026.
What was VentriPoint Diagnostics Ltd.'s operating margin in 2025?
In 2025, VentriPoint Diagnostics Ltd.'s operating margin was -1,889.37%, compared with -5,045.41% in 2024.
How has VentriPoint Diagnostics Ltd.'s operating margin changed since 2020?
From 2020 to 2025, VentriPoint Diagnostics Ltd.'s operating margin was highest in 2021 (0.00%) and lowest in 2023 (-10,024.80%).
How does VentriPoint Diagnostics Ltd.'s operating margin compare with similar companies?
VentriPoint Diagnostics Ltd.'s operating margin (-1,624.48%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.